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ABSTRACT
Objectives The current study examined predictors of 
outcomes of internet- based cognitive–behavioural therapy 
(ICBT) for individuals with tinnitus.
Design Secondary analysis of intervention studies.
Setting Internet- based guided tinnitus intervention 
provided in the UK.
Participants 228 individuals who underwent ICBT.
Interventions ICBT.
Primary and secondary outcome measures The 
key predictor variables included demographic, tinnitus, 
hearing- related and treatment- related variables as well as 
clinical factors (eg, anxiety, depression, insomnia), which 
can have an impact on the treatment outcome. A 13- point 
reduction in Tinnitus Functional Index (TFI) scores has 
been defined as a successful outcome.
Results Of the 228 subjects who were included in the study, 
65% had a successful ICBT outcome. As per the univariate 
analysis, participants with a master’s degree or above had 
the highest odds of having a larger reduction in tinnitus 
severity (OR 3.47; 95% CI 1.32 to 12.51), compared with the 
participants who had education only up to high school or less. 
Additionally, the baseline tinnitus severity was found to be a 
significant variable (OR 2.65; 95% CI 1.50 to 4.67) contributing 
to a successful outcome with the intervention. Both linear and 
logistic regression models have identified education level and 
baseline tinnitus severity to be significant predictor variables 
contributing to a reduction in tinnitus severity post- ICBT. 
As per the linear regression model, participants who had 
received disability allowance had shown a 25.3- point lower 
TFI reduction compared with those who did not experience a 
decrease in their workload due to tinnitus after adjusting for 
baseline tinnitus severity and their education level.
Conclusions Predictors of intervention outcome can be 
used as a means of triaging patients to the most suited 
form of treatment to achieve optimal outcomes and to 
make healthcare savings. Future studies should consider 
including a heterogeneous group of participants as well as 
other predictor variables not included in the current study.
 ClinicalTrial. gov Registration: NCT02370810 
(completed); NCT02665975 (completed)
INTRODUCTION
Tinnitus is the perception of sounds in the 
absence of external stimulation and is often 
heard as a ringing or buzzing meaningless 
sound(s). It is a very common condition with 
at least 15% of the adult population having 
tinnitus.1 Tinnitus is highly heterogeneous, 
both in the way it manifests as well as in the 
manner those with tinnitus respond to treat-
ment options.2 The National Study of Hearing 
in England found that of the general popula-
tion surveyed (N=48, 313), 10.1% reported 
any tinnitus, 2.8% reported moderately 
annoying tinnitus, 1.6% reported severely 
annoying tinnitus and 0.5% were unable to 
lead a normal life due to the severity of the 
tinnitus.1 Although there are several manage-
ment strategies described in the literature, 
most are not evidence based. The main excep-
tion is cognitive–behavioural therapy (CBT), 
as indicated in various systematic reviews of 
randomised controlled trials.3–6 Clinical prac-
tice guidelines based on research evidence 
and expert consensus recommend CBT as 
a management option for individuals with 
tinnitus and is supported by the American 
Academy of Otolaryngology- Head and Neck 
Surgery.7
Strengths and limitations of this study
 ► The current study, to our knowledge, is the first 
study to use combined data from multiple studies 
to examine the predictors of internet- based cogni-
tive–behavioural therapy (ICBT) outcome for tinnitus.
 ► The study included a homogeneous group of tinnitus 
patients due to the strict inclusion/exclusion criteria 
and may not have included all the possible variables 
(eg, health literacy, acceptability and motivation of 
users, satisfaction from the intervention, interven-
tion engagement) that may have played a role in 
ICBT outcome.
 ► The sample size remained relatively small when 
compared with the number of predictive factors in-
cluded which may have hampered the study results.
 ► The multivariable analyses may have some limita-
tions in terms of examining complex relationships. 
Other statistical models including artificial intelli-
gence and machine learning techniques may have 
more value in examining the non- linear relationship.
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Despite positive and strong evidence for CBT, individ-
uals with tinnitus are rarely offered CBT in their local 
clinics. For example, a large- scale epidemiological study 
in the USA showed that medication (which is not recom-
mended for tinnitus in clinical guidelines) was discussed 
50% of the time by health professionals, whereas the 
CBT was discussed as a management option only 0.2% 
of the time.8 This is most likely a consequence of the 
limited number of trained professionals who provide 
CBT for tinnitus. One solution to overcome this issue is 
to use Internet- based CBT (ICBT), in which patients are 
provided with CBT in a self- help format over the internet 
with minimal guidance from a tinnitus expert.9 A series 
of controlled studies in Sweden, Germany the UK and 
the USA have demonstrated positive effects of ICBT in 
reducing tinnitus distress as well as reducing its comor-
bidities such as anxiety, depression and insomnia.9 In 
addition to the changes noted in standardised outcome 
measures, the qualitative analysis of user experiences has 
highlighted the perceived benefits of this programme.10 
In addition, the improvements noted from ICBT have 
been maintained for 1- year postintervention.11 These 
results suggest that ICBT is a highly promising approach 
to provide evidence- based tinnitus management.
Although the previous studies on ICBT have shown 
favourable results, group effects were mainly reported. 
There is limited understanding of who is likely to benefit 
(or not) from the ICBT intervention. In other words, only 
a few studies have examined predictors of ICBT outcomes 
in tinnitus research. For example, the long- term analysis 
of the previous UK studies suggested that the best predic-
tors of tinnitus improvements at 1 year were the baseline 
tinnitus severity, engagement with ICBT programme (ie, 
more modules read) and higher self- reported satisfaction 
with the intervention.11 Studies in other health areas have 
also examined the predictors of outcome for a range of 
internet- based health interventions.12–16 These studies 
have inconsistently identified various demographic as 
well as disease- specific variables that could predict the 
successful and non- successful participants on internet 
interventions.16 There remains a clear gap in knowledge 
in terms of predictors of ICBT outcomes for tinnitus.
Predictors of intervention outcomes may help triage 
patients to the most suitable tinnitus intervention. If inter-
ventions are recommended based on their suitability, it 
can potentially improve the outcomes resulting in health-
care savings. The objective of the current study was to 
examine the predictors of outcomes of ICBT intervention 
for individuals with tinnitus based on the secondary anal-
ysis of the pooled results from the three- phase clinical 
trial undertaken in the UK.
METHOD
Study design and participants
A large data set was sought to identify predictors of 
outcome. Trials with similar methodologies were hence 
sought to merge to form a larger data set. Although a 
few previous studies regarding ICBT were conducted 
in Europe, extensive outcome measures were not used. 
Following these trials, three trials were conducted in 
the UK using the same outcome measures. These trials 
were used due to a lack of other controlled trials avail-
able to pool data from. This present study, thus, formed 
a secondary analysis of data collected from three separate 
ICBT trials. Study participants from the three separate 
trials with different designs including the single- group 
pretest and post- test design,17 an efficacy RCT design ( 
ClinicalTrials. gov: NCT02370810),18 and an effective-
ness RCT design (Clinical  Trials. gov: NCT02665975)19 
were combined. These studies were conducted during 
2016–2018. In the efficacy trial, the experimental group 
underwent ICBT immediately after allocation whereas 
the control group underwent the same intervention 
following an 8- week weekly check- in period. In the effec-
tiveness trial, the experimental group underwent the 
ICBT intervention whereas the control group underwent 
treatment as usual, consisting of in- person tinnitus coun-
selling and sound therapy, provided by the audiologists at 
three hospital settings. The data were collected from only 
those who underwent the ICBT intervention and were 
included in this study. The study team was granted access 
to the deidentified datasets, not containing any person-
ally identifiable information, as part of a data sharing 
policy. The study results are presented using the Trans-
parent Reporting of a multivariable prediction model for 
Individual Prognosis or Diagnosis checklist (see online 
supplemental file 1).
Combining the data from three trials resulted in the 
inclusion of 228 participants. Of these, 36 were from 
the pilot trial, 146 were from the efficacy trial and the 
remaining 46 were from the effectiveness trial.
Intervention
The intervention included a CBT programme that was 
specifically developed for individuals with tinnitus.20 
This intervention was originally developed by psychol-
ogists in Sweden,21 but later adapted by audiologists in 
the UK22 and the USA.23 The intervention was adminis-
tered using a secured ePlatform24 25 and presented in a 
self- help format. The intervention was presented over an 
8- week period, during which the users were given access 
to 2–3 modules each week. The CBT programme was 
divided into 21 modules, of which five were optional. The 
modules included content such as applied relaxation, 
thought analysis, cognitive restructuring, imagery and 
exposure techniques. Each module included text, images 
and videos to enhance the user experience. In addition, 
users were required to complete various exercises to 
engage them in the intervention. Although the interven-
tion was presented in a self- help format, the users had 
access to minimal guidance from an audiologist (EWB). 
Generally, this included examining weekly exercises users 
completed and providing feedback as well as answering 
any questions they may have in the secured messaging 
system. An average of 10 min per participant was spent 
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on providing guidance and support, although some users 
required more support.
Outcome measures
The study participants completed an extensive prein-
tervention questionnaire that collected data on demo-
graphics, tinnitus- related and treatment- related history. 
In addition, participants also completed various stan-
dardised patient- reported outcome measures at base-
line (T0), at postintervention (T1) and at the 2 month 
follow- up (T2). The primary outcome measure included 
the Tinnitus Functional Index (TFI)26 to assess tinnitus 
severity/distress. This is a 25- item questionnaire with 
scores ranging between 0 and 100. Scores below 25 indi-
cate mild tinnitus with no need for intervention, scores 
ranging between 25 and 50 indicate a significant problem 
with possible need for intervention, and scores above 50 
indicate severe enough tinnitus possibly requiring a more 
intensive intervention. The TFI has good psychometric 
properties with acceptable internal consistency (0.97) 
and test–retest reliability (0.8).26
The secondary outcome measures included the 
Insomnia Severity Index27 as a measure of insomnia, the 
generalised anxiety disorder28 as a measure of anxiety, the 
Patient Health Questionnaire29 as a measure of depression, 
the Hearing Handicap Inventory for Adults Screening 
version30 as a measure of self- reported hearing disability, 
the Hyperacusis Questionnaire31 to assess the presence 
hyperacusis (ie, reduced tolerance of everyday sounds), 
the Cognitive Failures Questionnaire32 was administered 
to assess cognitive functions, and the Satisfaction with 
Life Scales33 to assess the global life satisfaction.
Patient and public involvement
As a secondary analysis, no patients were involved in these 
studies. The data originate from individuals with tinnitus 
who had previously received CBT delivered via the 
internet (ie, ICBT). As the same protocol was followed 
for all study participants and all received the same inter-
vention, merging this data was possible.
Variables included in the predictive model
Outcome variable
The dependent variable was the pre- and post- intervention 
change in tinnitus distress based on the TFI score (TFI 
change). The 13- point change in TFI scores identified 
as a clinically meaningful (or significant) change by the 
original authors26 was used to define a clinically signifi-
cant intervention outcome.
Predictor variables
Predictor variables were selected based on clinical 
reasoning and findings from previous studies by Beukes et 
al11 (see online supplemental file 2 for details). Thirty- two 
variables were selected as potential predictor (indepen-
dent) variables and included demographic, tinnitus and 
hearing- related variables, tinnitus treatment related vari-
ables. Clinical factors are as follows:
 ► Demographic variables (n=7): age (dichotomous), 
gender (dichotomous), education level (ordinal), 
employment type (categorical), loud noise expo-
sure (dichotomous), diagnosed with a psychological 
condition (dichotomous), work less due to tinnitus 
(categorical).
 ► Tinnitus and hearing- related variables (n=15): base-
line tinnitus severity (dichotomous), tinnitus duration 
(dichotomous), how often tinnitus heard (ordinal), 
tinnitus location (categorical), tinnitus types (nine 
different types, dichotomous), multiple tones heard 
(dichotomous) and hearing loss (categorical).
 ► Treatment- related to tinnitus (n=4): past treatment 
sought (dichotomous), sounds can distract from 
tinnitus (ordinal), hearing aid use (categorical) and 
medication use (dichotomous).
 ► Clinical factors (n=7): anxiety (dichotomous), 
depression (dichotomous), insomnia (dichoto-
mous), hyperacusis (dichotomous), hearing disability 
(dichotomous), cognitive functions (dichotomous) 
and life satisfaction (dichotomous).
Data analysis
The data were analysed using descriptive statistics as well 
as univariate and multivariable linear regression and 
logistic regression models. Linear models were used to 
identify the factors affecting a significant TFI score change 
while the logistic model was used to evaluate the factors 
which specifically effect outcomes and was thus selected. 
There were 98 subjects who had all their predictive vari-
ables except their post TFI scores. With the intention of 
preserving the power of the analysis, we have retained 
those subjects in the analysis after applying the predictive 
mean matching (PMM) data imputation.34 Data imputa-
tion with PMM has been identified to be less vulnerable 
to model misspecification as there is no need to define an 
explicit model for the distribution of the missing values.35
The univariate analysis was performed using χ2 or Fish-
er’s exact test to examine the effect of single variables on 
the ICBT outcome using all the variables. The multivari-
able regression model was used to identify the effect of the 
variables on tinnitus reduction post ICBT while adjusting 
for the baseline tinnitus severity as a variable previously 
identified to relate to the success of ICBT.11 Prior to the 
multivariable analyses, the full data set was divided into 
training (80%, n=183) and testing (20%, n=45) to make 
a fair comparison among all the predictive models. The 
training data set was used to develop the corresponding 
multivariable regression models while the testing data 
set was used to evaluate the model predictions. Several 
competing multivariable models (both linear and 
logistic) were examined. The best models were selected 
based on the lowest mean squared error and the lowest 
Akaike information criterion (AIC).36 During multivari-
able analysis, we began with the full model, including all 
the predictor variables and used backward elimination 
based on AIC to select the final model. R squared and 
adj. R squared values have been reported, as they are 
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statistical measures of fit that indicate how much variation 
of the outcome is explained by the predictor variable(s) 
in a linear regression model.37 We also reported the 
mean squared error as it is a better measure of prediction 
accuracy. Both crude and model- based ORs were calcu-
lated and used to evaluate the effect of the variable. The 
Hosmer- Lemeshow goodness- of- fit statistic was calculated 
to assess the calibration of the final model.38
The dependent variable TFI change was used as a 
continuous variable for a linear regression analysis 
whereas the dichotomous variable (ie, 13- point change 
yes or no) was used for logistic regression analysis. All 
statistical analyses were performed with R statistical soft-
ware (V.3.6.3). All tests were two sided and threshold at 
5% level of significance.
RESULTS
Participant demographics
The mean age of study participants was 55.14 (SD: 12.92) 
years, and 57% of the subjects (n=130) were males. The 
mean tinnitus duration was 17.68 (SD: 19.42) years. 
Further details on demographic, tinnitus, hearing- related 
and treatment- related variables are provided in online 
supplemental file 2 (tables 1-4). Table 1 presents details 
on clinical variables. The mean baseline tinnitus severity 
and tinnitus severity following the ICBT intervention were 
57.93 (SD: 19.17) and 34.22 (SD: 22.76), respectively. 
Figure 1 presents the preintervention and postinterven-
tion tinnitus severity (TFI) score variation, indicating 
statistically significant differences between these scores 
(p<0.001) with the paired t- test. There were 148 partici-
pants (65%) with a 13- point or higher reduction after the 
intervention.
Univariate analysis to examine the predictors of ICBT outcome
With the exception of education level (p=0.01), none 
of the demographic variables were associated with post- 
intervention tinnitus severity change of 13 points or 
more. Participants with a master’s degree or above had 
the highest odds of having a larger severity change score, 
with an OR of 3.47 (95% CIs 1.32 to 12.51), compared 
with the participants who had education only up to high 
school or less. In terms of tinnitus and hearing- related 
variables, the baseline tinnitus severity (p=0.001) was 
significantly associated with treatment success. Partici-
pants who had a higher baseline tinnitus severity (ie, TFI 
scores of greater than or equal to 55.2) had significantly 
higher odds of treatment success (OR 2.65; 95% CIs 1.50 
to 4.67) compared with those who had a baseline severity 
less than 55.2. The details of the univariate analyses are 
provided in online supplemental file 3 (tables 1–5).
In terms of the treatment- related variables, sounds can 
distract (p=0.001) showed a significant association with 
treatment success. Those who reported being distracted 
by the sound partially (OR 4.34; 95% CI 1.82 to 10.34) or 
not at all (OR 3.15; 95% CIs 0.99 to 10.00) were at higher 
odds of having a successful treatment outcome when 
compared with those who were fully distracted. However, 
the odds among the participants who used hearing aids 
either in one ear or both ears compared with those who 
did not were not statistically significantly different with 
a p=0.26 (see online supplemental table 4). Tinnitus 
described as voice- like had a 91% lower odds of success 
Table 1 Details of clinical variables of the study 
participants
Characteristic Mean (SD)
Preintervention tinnitus severity (measured 
using TFI, scores range 0–11)
57.93 (19.17)
Postintervention tinnitus severity (measured 
using TFI, scores range 0–11)
34.22 (22.76)
2- month follow- up tinnitus severity 
(measured using TFI, scores range 0–11)
34.23 (24.19)
Anxiety (measured using GAD-7, scores 
range 0–21)
7.29 (5.52)
Depression (measured using PHQ-9, scores 
range 0–27)
7.61 (5.73)
Insomnia (measured using ISI, scores range 
0–28)
12.49 (6.67)
Hyperacusis (measured using HQ, scores 
range 0–40)
18.33 (9.05)
Hearing disability (measured using the 
HHIA- S, scores range 0–40)
16.18 (11.64)
Cognitive failures (measured using the CFQ, 
scores range 0–100)
38.54 (15.63)
Life satisfaction (measured using SWLS, 
scores range 0–40)
20.71 (7.55)
CFQ, Cognitive Failures Questionnaire; GAD-7, generalised anxiety 
disorder; HHIA- S, Hearing Handicap Inventory for Adults Screening 
; HQ, Hyperacusis Questionnaire; ISI, Insomnia Severity Index; 
PHQ-9, Patient Health Questionnaire; SWLS, Satisfaction with Life 
Scales; TFI, Tinnitus Functional Index.
Figure 1 Tinnitus severity (TFI scores) preintervention 
and postintervention. Boxplot represents the five- number 
summary (minimum, first quartile, median, third quartile and 
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with the treatment. None of the clinical factors were 
significantly associated with the outcome.
Multivariable analyses to examine predictors of ICBT outcome
Working less due to tinnitus (p=0.046), baseline tinnitus 
severity (p<0.001) and education level (p=0.014), showed 
significant associations with outcome (ie, TFI reduction). 
Modified models with the remaining variables were not 
statistically significant. Moreover, several two- way inter-
actions were tested. We did not find any gender interac-
tions with regard to the maskability of sounds (p=0.87) 
and) and hearing aid usage (p=0.68) variables. The 
overall model resulted with an R squared=0.35 and Adj. R 
squared of 0.20. The final model resulted in a root mean 
square of 22.81on the testing data set. All required regres-
sion assumptions were satisfied with the selected model. 
The final regression model (see table 2) was selected with 
backward elimination based on AIC.
This model indicated that those who received disability 
allowance due to having severe tinnitus and being unable 
to work had shown a reduction of 25.30 points (95% CIs 
–46.35 to –4.24) in TFI compared with those who did not 
have to work less due to tinnitus. Moreover, for every 10 
unit increase in the baseline tinnitus severity, there was a 
8.3 points (95% CIs 0.65 to 1.00) reduction in their TFI 
score after adjusting for other variables. Participants who 
had master’s degree or above compared with participants 
who had a college education showed an expected reduc-
tion of 17 points (95% CIs 5.78 to 27.84) in their TFI 
score.
Multivariable logistic regressions were performed next 
and indicated that baseline tinnitus severity (p<0.001) 
and education level (p=0.001) were identified as signifi-
cant predictors (see table 3). This model had an AIC of 
212.21. Modified models to the prior model indicated 
that other variables were not statistically significant (see 
table 4).
The multivariable model adjusted OR (see table 3) 
for the participants who had master’s level or above 
Table 2 The best multiple linear regression model summary
Predictor variable Estimate 95% CI P value
Intercept −28.94 −41.70 to 16.18 <0.0000
Work less: no Ref
Work less: reduced hours −6.25 −23.90 11.39 0.48
Work less: stopped work −0.58 −10.52 to 9.36 0.91
Work less: disability allowance −25.30 −46.35 to 4.24 0.02
Baseline tinnitus severity 0.83 0.65 to 1.00 <0.0001
Education level: high school or less Ref
Education level: college −2.25 −12.61 to 8.11 0.67
Education level: vocational training 0.98 −10.29 to 12.25 0.86
Education level: batchelor’s degree 5.14 −4.13 to 14.42 0.28
Education level: master’s degree or above 16.81 5.78 to 27.84 0.003
CI, Confidence Interval 
.
Table 3 The multivariable logistic regression model summary and the model adjusted OR (95% CI) for successful ICBT 
outcome of 13 points of higher
Estimate P value Model- based adjusted OR (95% CI for OR)
Intercept −2.32 0.0005 0.10 (0.03 to 0.37)
Baseline tinnitus severity 0.04 <0.001 1.04 (1.02 to 1.06)
Education level: high school or less Ref
Education level: college −0.4 0.41 0.67 (0.26 to 1.74)
Education level: vocational training 0.41 0.47 1.49 (0.50 to 4.48
Education level: batchelor’s degree 0.68 0.14 1.98 (0.79 to 4.98)
Education level: master’s degree or above 2.27 0.001 9.65 (2.32 to 40.15)
CI, Confidence Interval 
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education compared with those who had high school 
education or less also showed 9.65 higher odds (95% CIs 
2.32 to 40.15) of having a successful outcome. Similar to 
the linear regression model, baseline tinnitus severity had 
also shown a significant association (OR 1.04; 95% CIs 
1.02 to 1.06) with the treatment outcome. The Hosmer- 
Lemeshow goodness- of- fit test confirmed a better fit in 
the current model with a p- value of 0.50 ( χ2  =7.36, df=8).
Fewer variables were statistically significant in the 
logistic regression model, which identified influencing 
predictors of the ICBT success. This was due to the fact 
that the logistic regression model evaluated predictors 
of treatment successes (ie, 13- point change), while the 
multivariable regression model identified the predictors 
of a significant TFI reduction.
DISCUSSION
Accessible and affordable tinnitus interventions are 
needed to alleviate tinnitus distress as well as comorbid 
problems with anxiety, depression and insomnia. The 
current study examined predictors of outcomes for ICBT. 
In this exploratory study, only a limited number of vari-
ables were identified as possibly reducing tinnitus severity 
scores on the TFI by at least 13 points following ICBT 
intervention, and the results vary depending on the model 
Table 4 Predictor variables which were insignificant in multivariable regression models
Predictor variable
P value
Multivariable linear regression model
Multivariable logistic 
regression model
1 Gender 0.47 0.83
2 Hearing loss 0.89 0.72
3 Tinnitus type: ringing 0.38 0.91
4 Tinnitus type: buzzing 0.43 0.53
5 Tinnitus type: high pitch 0.56 0.48
6 Tinnitus type: low pitch 0.33 0.46
7 Tinnitus type: pulsing 0.99 0.34
8 Tinnitus type: clicking 0.09 0.01
9 Tinnitus type: music 0.37 0.69
10 Tinnitus type: voices 0.34 0.09
11 Tinnitus type: humming 0.96 0.06
12 Anxiety 0.07 0.48
13 Depression 0.76 0.86
14 Insomnia 0.94 0.53
15 Hyperacusis 0.75 0.53
16 Hearing disability 0.84 0.57
17 Cognitive functions 0.71 0.72
18 Life satisfaction 0.75 0.84
19 Multiple tones heard 0.26 0.81
20 Loud noise exposure 0.32 0.76
21 Work less due to tinnitus Refer table 2 0.46
22 Presence of a psychological condition 0.88 0.72
23 Past treatment sought 0.60 0.83
24 Hearing aid use 0.21 0.20
25 Sounds can distract 0.51 0.11
26 Medication use 0.73 0.87
27 Tinnitus location 0.50 0.27
28 Employment type 0.63 0.90
29 Age 0.88 0.70
30 Tinnitus duration 0.17 0.93
31 How often tinnitus is heard 0.23 0.57
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used. Only educational level and baseline tinnitus severity 
were predictors in both linear and logistic models. The 
other significant variable in the linear regression models 
included the demographic variable, work restrictions due 
to tinnitus when controlling for baseline tinnitus severity 
and education level. These key findings are discussed 
below.
In terms of demographic variables, education level 
was found to be a significant predictor of ICBT success 
as those with a master’s education or higher had higher 
odds of having a successful outcome compared with those 
with high school education in both the linear and logistic 
models. This was expected as having good literacy skills 
is essential when understanding the intervention mate-
rials. The intervention materials used in these studies 
were written at an average of ninth- grade reading level23 
suggesting that they were not easily accessible for partic-
ipants with only a high school education. These results 
highlight the importance of health literacy consider-
ations when developing text- based self- help interventions 
such as ICBT. Additionally, those who reported work 
restrictions due to tinnitus were at a lower odds of having 
a successful outcome. This finding needs further explora-
tion in future studies. Working may, for instance, provide 
some distraction from tinnitus as supported by reports 
during the 2020 COVID-19 pandemic that tinnitus was 
more bothersome for some individuals due to the lack 
of distractions from commuting and sounds at work.39 
Closely monitoring the effects of tinnitus is important to 
ensure that tinnitus can be managed so that individuals 
are still able to work effectively.
When examining the tinnitus and hearing- related 
variables, baseline tinnitus severity was found to be 
a significant predictor of ICBT success, as seen in 
previous studies.11 Tinnitus perceptions vary greatly, 
and in this study, those with tinnitus presenting as 
musical, lower- pitched or clicking were less likely 
to have a positive outcome of ICBT. This finding 
certainly needs further exploration as the limited 
number of participants in each group of tinnitus 
perception. One of the CBT intervention aims is to 
help participants to reinterpret their tinnitus to a less 
threatening sound. It may be that these sounds are not 
easily likened to everyday sounds than other types of 
tinnitus (ie, buzzing, high pitch, pulsing, humming) 
making it difficult to develop adaptation strategies.
Of the four treatment- related variables, only those who 
reported to use of wearing one hearing aid were found 
to be at better odds of ICBT success. This finding needs 
further exploration to identify other characteristics 
that may be associated with an outcome such as having 
tinnitus in only one ear. Although the evidence for the 
use of hearing aids alone for tinnitus management is 
limited,40 41 hearing aids may for some reduce the tinnitus 
percept and aid communication difficulties.42 Ensuring 
hearing loss is addressed in addition to the provision of 
ICBT may lead to more optimal outcomes for those with 
coexisting hearing loss.
Regarding studying the clinical factors, those with 
higher levels of depression were found to have a higher 
reduction in the TFI score. However, the participants 
with insomnia showed lower odds of success. Interest-
ingly, other clinical factors including anxiety, hyperacusis, 
hearing disability as well as cognitive functioning were 
not significant predictors of ICBT in the current study. 
Further studies and models are required to verify these 
results.
Studies in other health areas have also examined the 
predictors of a range of internet- based health interven-
tions.12–15 Generally, higher baseline symptoms predict 
increased treatment response, as in anxiety and depres-
sion,43 and higher obsessive–compulsive behaviours when 
treating the obsessive- compulsive disorder.44 Variables 
such as age and gender have been mentioned as signif-
icant predictors for some ICBT interventions.15 43 Most 
previous ICBT interventions have not identified pretreat-
ment characteristics to predict or moderate outcomes.16 
Most ICBT studies have indicated that ICBT works irre-
spective of treatment history.43 Contrarily, previous 
treatment has shown worse outcomes in some previous 
studies.45 However, it may be that some participants may 
have sought alternative therapies which have no evidence 
for tinnitus. For this reason, it would be useful to examine 
specific types of previous treatments in future studies to 
distinguish between those who had evidence- based inter-
ventions before enrolling to ICBT than those who did 
not.
Study limitations and future research
The current study was to our knowledge the first study 
to combine data from multiple studies to examine the 
predictors of ICBT outcome for tinnitus. However, it 
has limitations. First, the study may have included a 
homogeneous group of tinnitus patients due to study 
inclusion/exclusion criteria and may not have included 
all the possible variables (eg, health literacy, accept-
ability and motivation of users, satisfaction from the 
intervention, intervention engagement) that may have 
played a role in ICBT outcome. These factors were not 
investigated for this study. As they have been found to 
contribute to outcomes,46 they should be included in 
future studies. Second, the sample size remained rela-
tively small when compared with the number of predic-
tive factors included. Third, multivariable analyses may 
have some limitations in terms of examining complex 
relationships. Moreover, due to the high multicol-
linearity between the predictor variables, there were 
several competing models which had led to the same 
prediction accuracies and root mean square errors. 
Additionally, these linear models lack in identifying any 
predictor variables that have a non- linear relationship 
with the response variables. For these reasons, the study 
results must be viewed as preliminary. Future studies 
may benefit from using non- linear statistical models 
such as generalised additive models, and also artificial 
intelligence and machine learning models like neural 
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networks, random forest and support vector machines, 
as some variables like tinnitus duration and depression 
had shown lower correlation with the response (with 
correlations: −0.10 and 0.29, respectively). In addi-
tion, including more relevant predictive factors (eg, 
health literacy, motivation, engagement, adherence) 
in future studies may help improve predictive accu-
racy. Currently, we have used AIC value to compare 
the competing models. For future studies, we are plan-
ning to use average Area Under the Receiver Oper-
ating Characterastic curve (AUC) and Brier scores to 
compare models.
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Supplementary File 1 
 
Table 1: TRIPOD Checklist – Prediction model development  
 
Section/Topic Item Checklist Item Page 
Title and abstract 
Title 1 
Identify the study as developing and/or validating a multivariable prediction model, 
the target population, and the outcome to be predicted. 
1 
Abstract 2 
Provide a summary of objectives, study design, setting, participants, sample size, 






Explain the medical context (including whether diagnostic or prognostic) and 
rationale for developing or validating the multivariable prediction model, including 
references to existing models. 
3-5 
3b 
Specify the objectives, including whether the study describes the development or 
validation of the model or both. 
5 
Methods 
Source of data 
4a 
Describe the study design or source of data (e.g., randomized trial, cohort, or 
registry data), separately for the development and validation data sets, if applicable. 
6 
4b 
Specify the key study dates, including start of accrual; end of accrual; and, if 




Specify key elements of the study setting (e.g., primary care, secondary care, 
general population) including number and location of centres. 
6 
5b Describe eligibility criteria for participants.  6 
5c Give details of treatments received, if relevant.  6-7 
Outcome 
6a 
Clearly define the outcome that is predicted by the prediction model, including how 
and when assessed.  
8-9 
6b Report any actions to blind assessment of the outcome to be predicted.  NA 
Predictors 
7a 
Clearly define all predictors used in developing or validating the multivariable 
prediction model, including how and when they were measured. 
8-9 
7b 
Report any actions to blind assessment of predictors for the outcome and other 
predictors.  
NA 
Sample size 8 Explain how the study size was arrived at. 9 
Missing data 9 
Describe how missing data were handled (e.g., complete-case analysis, single 





10a Describe how predictors were handled in the analyses.  10 
10b 
Specify type of model, all model-building procedures (including any predictor 
selection), and method for internal validation. 
10 
10d 
Specify all measures used to assess model performance and, if relevant, to 
compare multiple models.  
10 




Describe the flow of participants through the study, including the number of 
participants with and without the outcome and, if applicable, a summary of the 
follow-up time. A diagram may be helpful.  
11 
13b 
Describe the characteristics of the participants (basic demographics, clinical 
features, available predictors), including the number of participants with missing 




14a Specify the number of participants and outcome events in each analysis.  11 
14b 






Present the full prediction model to allow predictions for individuals (i.e., all 
regression coefficients, and model intercept or baseline survival at a given time 
point). 
12-15 
15b Explain how to the use the prediction model. 14-15 
Model 
performance 
16 Report performance measures (with CIs) for the prediction model. 14-15 
Discussion 
Limitations 18 
Discuss any limitations of the study (such as nonrepresentative sample, few events 
per predictor, missing data).  
18-19 
Interpretation 19b 
Give an overall interpretation of the results, considering objectives, limitations, and 
results from similar studies, and other relevant evidence.  
15-18 





Provide information about the availability of supplementary resources, such as study 
protocol, Web calculator, and data sets.  
9, 11 
Funding 22 Give the source of funding and the role of the funders for the present study.  19 
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Supplementary File 2: Predictor Variables  
 
Table 1: Demographic variables 
 
Variable Question Response options 
 Age What is your age? In years 
 
Split into dichotomous variables 
(<=57 years of age and >57 years 
of age) based on the median 
Gender What is your gender? Male (1), Female (2) 
Education level 
 
What is the highest level of 
education you have completed?  
Highschool or less (1), College (2), 
Vocational training (3), Bachelor’s 





What best describes your 
employment? 
 
Manager (1), Professional (2), 
Technical (3), Administrative (4), 
Skilled tradesman (5), Service 
occupation (6), Medical (7), Sales 
(8), Home maker (9), Student (10), 
Retired (11), Unemployed (12) 
Loud noise 
exposure 
Have you been exposed to loud 
noise? 




Have you been presently diagnosed 
with any psychological conditions 
including anxiety and depression? 
Yes (1) , No (0) 
Work less due to 
tinnitus 
Do you work less because of your 
tinnitus? 
No (0), Reduced hours (1), Stopped 
work (2), Disability allowance (3) 
 
 
Table 2: Tinnitus and hearing-related variables  
 
Variable Question Response options 
Baseline tinnitus 
severity  
Measured using the Tinnitus Functional 
Index (TFI) 
Scores range from 0 to 100.  
 
Split into dichotomous variables 
(<=55.2 and >55.2) based on the 
median 
Tinnitus duration How long have you had tinnitus for? In years 
 
Split into dichotomous variables 
(<=10.00 years and >10.00 years) 
based on the median 
How often is 
tinnitus heard? 
How often is tinnitus heard?  Occasionally (1), When taking 
out my hearing aid(s) (2), At 
night (3), Most of the time (4), 
All the time (5) 
Tinnitus location Where do you notice your tinnitus? One ear (1), Both ears (2), In my 
head (3), Unsure (4), Other (5) 
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Type of tinnitus 
(9 different 
types) 
§ Ringing  
§ Buzzing 
§ High pitched sound 










This variable is computed based on 
responses to types of tinnitus. Answer 
yes to multiple types of tinnitus was 
considered as multiple tones heard 
Yes (1) , No (0) 
Presence of a 
hearing loss 




Table 3: Treatment-related variables 
 
Variable Question Response options 
Past treatment 
sought 
Have you received treatment for tinnitus in 
the past? 





How well can sounds around you distract 
you from your tinnitus or make the tinnitus 
less noticeable? 
Fully (1), Partially (2), Not at 
all (3) 
 
Hearing aid use Do you wear hearing aid(s) or any other 
amplification devices? 
No (0), One ear (1), Both ears 
(2)  
Medication use Do you currently take any medications? Yes (1) , No (0) 
 
 
Table 4: Clinical factors 
 









4-point scale with 
“not at all” (score of 
0) to “nearly every 
day” (score of 3) 
Higher number indicates more severe 
anxiety (scores range between 0–21). 
The total score is interpreted as 
follows:  
§ 0–4: minimal anxiety 
§ 5–9: mild anxiety 
§ 10–14: moderate anxiety 
§ 15–21: severe anxiety 
 
Split into dichotomous variables (<=9 
no anxiety and >9 anxiety)  





4-point scale with 
“not at all” (score of 
Higher number indicates more severe 
depression (scores range between 0–
27). 
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0) to “nearly every 
day” (score of 3) 
The total score is interpreted as 
follows:  
§ 5–9: mild depression 
§ 10–14: moderate 
§ 15–19: moderately severe 
§ 20–18: severe depression 
 
Split into dichotomous variables (<=14 






5-point scale with 
“no problem” (score 
of 0) to “very severe 
problem” (score of 4) 
Higher number indicates more severe 
insomnia (scores range between 0–
28). 
 
The total score is interpreted as 
follows:  
§ 0–7: not clinically significant 
§ 8–14: subthreshold insomnia 
§ 15–21: clinical insomnia 
(moderate severity) 
§ 22–28: clinical insomnia (severe 
degree) 
 
Split into dichotomous variables 






4-point scale with 
“no” (score of 0) to 
“yes, a lot” (score of 
3) 
Higher number more severe 
hyperacusis (scores range between 0–
42). 
 
The total score is interpreted as 
follows:  
§ >28: strong hypersensitivity 
 
Split into dichotomous variables 












3-point scale with 
“yes” (score of 4) to 
“no” day (0) 
Higher number more severe hearing 
disability (scores range between 0–
40). 
 
The total score is interpreted as 
follows:  
§ 0–8: no hearing disability 
§ 10–24: mild to moderate hearing 
disability   
§ 26–40: severe hearing disability 
 
Split into dichotomous variables (<=8 
no hearing disability and >=10 hearing 
disability) 
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5-point scale with 
“never” (score of 0) 
to “very often” 
(score of 4) 
Higher scores indicate more 
difficulties (cognitive failures) in 
perception, memory, and motor 
function (score range 0–100). 
 
The total score is interpreted as 
follows:  
The scores range 0–100 with higher 
scores indicating more cognitive 
failures/problems (or reduced 
cognitive functioning).  
 
Split into dichotomous variables 









7-point scale with 
“strongly disagree” 
(score of 1) to 
“strongly agree” (7) 
Higher number indicated more 
satisfaction with life (scores range 
between 5–35). 
 
The total score is interpreted as 
follows:  
§ 0–9: extremely dissatisfied  
§ 10–14: dissatisfied  
§ 15–19: below average 
satisfaction  
§ 20–24: average satisfaction   
§ 25–29: high satisfaction  
§ 30–35: highly satisfied   
 
Split into dichotomous variables 
(<=19 life satisfaction and >19 high 
satisfaction) 
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Supplementary File 3: Univariate analysis to examine association between predictor 
variables and outcome variable 
 
Table 1: Participant demographic characteristics (n=228) 
 
Characteristic N (%) Mean (SD) 
Demographic characteristics 










Highest level of education 
§ High school or below 
§ College 
§ Vocational training 
§ Bachelor’s degree 













§ Skilled tradesman 




§ Student  






























Working less due to tinnitus 
§ Reduced hours 
§ Stopped work 








Tinnitus and hearing-related characteristics 
Baseline tinnitus severity (measured using 
Tinnitus Functional Index) 
 57.93 (19.17) 
Tinnitus duration (in years)  17.68 (19.42) 
How often tinnitus is heard   
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§ Occasionally 
§ When taking out my hearing aid(s) 
§ At night 
§ Most of the time 







§ One ear  
§ Both ears 
§ In my head 









Type of tinnitus sound (answering Yes) 
§ Ringing 
§ Buzzing 
§ High pitched sound 
§ Low pitched sound 
§ Pulsating 
§ Clicking 





















Presence of a hearing loss 
§ No 
§ Both ears 
















Sounds can distract from tinnitus 
§ Fully 
§ Partially 
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Table 2: Univariate analysis with the Chi-square/ Fishers exact test results on the association 
between the demographic predictor categories and outcome variable (success as defined by a 
TFI-score changes >=13 points or a failure). *Indicates use of Fisher's exact test results due to 
less than 5 cases in subcategories.  
 
Predictor variable Sub-Categories Crude Odds Ratio 
(95% CIs) 
P-Value  
Age >57 years 0.85 (0.50, 1.47) 0.57 
<=57 years Ref  
Gender Female  1.12 (0.64, 1.94) 0.70 
Male Ref  
Education level College 0.61 (0.31, 1.42) 0.01* 
Vocational training 1.70 (0.75, 4.88)  
Bachelor's degree 1.30 (0.67, 2.92)  
Master's degree or above 3.47 (1.32, 12.51)  
High school or less Ref  
Employment type Professional 0.59 (0.25, 1.82) 0.95* 
Technical 0.40 (0.13, 1.89)  
Administrative 0.40 (0.14, 1.66)  
Skilled tradesman 0.56 (0.18, 3.00)  
Service occupation 0.80 (0.24, 4.66)  
Medical 1.00 (0.22, 11.54)  
Sales 0.80 (0.21, 6.00)  
Home maker 0.27 (0.06, 3.00)  
Student 0.40 (0.05, 35.47)  
Retired 0.74 (0.32, 2.12)  
Unemployed 0.80 (0.24, 4.66)  
Manager Ref  
Loud noise exposure Yes 0.80 (0.46, 1.38) 0.43 
No Ref  
Presence of a 
psychological condition 
Yes 1.72 (0.85, 3.46) 0.13 
No Ref  
Work less due to 
tinnitus 
Reduced hours 1.05 (0.31, 6.18) 0.89* 
Stopped work 0.81 (0.41, 1.89)  
Disability allowance 0.53 (0.16, 2.88)  
No Ref  
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Table 3: Univariate analysis with the Chi-square/ Fishers exact test results on the association 
between the tinnitus and hearing-related predictor categories and outcome variable (success as 
defined by a TFI-score changes >=13 points or a failure). *Indicates use of Fisher's exact test 
results due to less than 5 cases in subcategories.  
Predictor variable Sub-Categories Crude Odds Ratio 
(95% CIs) 
P-Value  
Baseline tinnitus severity >55.2 2.65 (1.50, 4.67) 0.001 
 <=55.2 Ref  
Tinnitus duration >10.00 years  1.16 (0.66, 2.02) 0.60 
<=10.00 years Ref  
How often tinnitus is heard  When taking out my 
hearing aid(s) 
0.67 (0.02, 18.06) 0.19* 
At night 0.33 (0.02, 6.65)  
Most of the time 0.39 (0.04, 3.96)  
All the time 0.76 (0.08, 7.49)  
Occasionally Ref  
Tinnitus location Both ears 1.41(0.48, 4.16) 0.90* 
In my head  0.94 (0.48, 1.80)  
Unsure 1.35 (0.55, 3.34)  
Other  1.13 (0.10,13.16)  
One ear Ref  
Tinnitus type: Ringing Yes 1.30 (0.72, 2.37) 0.38 
No Ref  
Tinnitus type: Buzzing Yes 1.34 (0.74, 2.42) 0.32 
No Ref  
Tinnitus type: High pitch Yes 0.76 (0.44, 1.33) 0.34 
No Ref  
Tinnitus type: Low pitch Yes 0.89 (0.31, 2.56) 0.83 
No Ref  
Tinnitus type: Pulsing Yes 0.97 (0.42, 2.21) 0.94 
No Ref  
Tinnitus type: Clicking Yes 0.52 (0.17, 1.53) 0.23 
No Ref  
Tinnitus type: Music Yes 1.63 (0.17, 15.98) 1.00* 
No Ref  
Tinnitus type: Voices Yes 0.09 (0.00, 1.75) 0.04* 
No Ref  
Tinnitus type: Humming Yes 0.56 (0.23, 1.39) 0.21 
No Ref  
Multiple tones heard Yes 1.15 (0.64, 2.08) 0.63 
No Ref  
Presence of a hearing loss Both ears 1.20 (0.59, 2.41) 0.92 
One ear 1.19 (0.51, 2.74)  
Unsure 1.41 (0.53, 3.73)  
No Ref  
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Table 4: Univariate analysis with the Chi-square/ Fishers exact test results on the association 
between the treatment-related predictor categories and outcome variable (success as defined by a 
TFI-score changes >=13 points or a failure). *Indicates use of Fisher's exact test results due to 
less than 5 cases in subcategories.  
 
Predictor variable Sub-Categories Crude Odds Ratio 
(95% CIs) 
P-Value  
Past treatment sought Yes 0.94 (0.50, 1.74) 0.83 
No Ref  
Sounds can distract Partially 4.34 (1.82, 10.34) 0.001 
Not at all 3.15 (0.99, 10.00)   
Fully Ref  
Hearing aid use One ear 1.57 (0.61, 5.49) 0.26 
Both ear 0.69 (0.38, 1.39)  
No Ref  
Medication use Yes 1.22 (0.71, 2.12) 0.46 
No Ref  
 
 
Table 5: Univariate analysis with the Chi-square/ Fishers exact test results on the association 
between the clinical factors predictor categories and outcome variable (success as defined by a 
TFI-score changes >=13 points or a failure). *Indicates use of Fisher's exact test results due to 
less than 5 cases in subcategories.  
 
 
Predictor variable Sub-Categories Odds Ratio (95% 
CIs) 
P-Value  
Anxiety Yes 1.53 (0.83, 2.82) 0.17 
No Ref  
Depression Yes 1.54 (0.62, 3.83) 0.35 
No Ref  
Insomnia Yes 1.27 (0.72, 2.23) 0.41 
No Ref  
Hyperacusis Yes 1.21 (0.56, 2.63) 0.62 
No Ref  
Hearing disability Yes 1.37 (0.77, 2.43) 0.28 
No Ref  
Cognitive functions Yes 0.99 (0.56, 1.74) 0.97 
No Ref  
Life satisfaction  Yes 0.76 (0.44, 1.33) 0.34 
No Ref  
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Supplementary File 1 
 
Table 1: TRIPOD Checklist – Prediction model development  
 
Section/Topic Item Checklist Item Page 
Title and abstract 
Title 1 
Identify the study as developing and/or validating a multivariable prediction model, 
the target population, and the outcome to be predicted. 
1 
Abstract 2 
Provide a summary of objectives, study design, setting, participants, sample size, 






Explain the medical context (including whether diagnostic or prognostic) and 
rationale for developing or validating the multivariable prediction model, including 
references to existing models. 
1 
3b 
Specify the objectives, including whether the study describes the development or 
validation of the model or both. 
1 
Methods 
Source of data 
4a 
Describe the study design or source of data (e.g., randomized trial, cohort, or 
registry data), separately for the development and validation data sets, if applicable. 
2 
4b 
Specify the key study dates, including start of accrual; end of accrual; and, if 




Specify key elements of the study setting (e.g., primary care, secondary care, 
general population) including number and location of centres. 
2 
5b Describe eligibility criteria for participants.  2 
5c Give details of treatments received, if relevant.  2-3 
Outcome 
6a 
Clearly define the outcome that is predicted by the prediction model, including how 
and when assessed.  
3 
6b Report any actions to blind assessment of the outcome to be predicted.  NA 
Predictors 
7a 
Clearly define all predictors used in developing or validating the multivariable 
prediction model, including how and when they were measured. 
3 
7b 
Report any actions to blind assessment of predictors for the outcome and other 
predictors.  
NA 
Sample size 8 Explain how the study size was arrived at. 2 
Missing data 9 
Describe how missing data were handled (e.g., complete-case analysis, single 





10a Describe how predictors were handled in the analyses.  3 
10b 
Specify type of model, all model-building procedures (including any predictor 
selection), and method for internal validation. 
3 
10d 
Specify all measures used to assess model performance and, if relevant, to 
compare multiple models.  
3 




Describe the flow of participants through the study, including the number of 
participants with and without the outcome and, if applicable, a summary of the 
follow-up time. A diagram may be helpful.  
3 
13b 
Describe the characteristics of the participants (basic demographics, clinical 
features, available predictors), including the number of participants with missing 




14a Specify the number of participants and outcome events in each analysis.  3 
14b 






Present the full prediction model to allow predictions for individuals (i.e., all 
regression coefficients, and model intercept or baseline survival at a given time 
point). 
3-5 
15b Explain how to the use the prediction model. 3-5 
Model 
performance 
16 Report performance measures (with CIs) for the prediction model.  3-5 
Discussion 
Limitations 18 
Discuss any limitations of the study (such as nonrepresentative sample, few events 
per predictor, missing data).  
7 
Interpretation 19b 
Give an overall interpretation of the results, considering objectives, limitations, and 
results from similar studies, and other relevant evidence.  
6-7 





Provide information about the availability of supplementary resources, such as study 
protocol, Web calculator, and data sets.  
2 
Funding 22 Give the source of funding and the role of the funders for the present study.  8 
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